These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9044167)

  • 1. Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.
    Cheng H; Gillespie WR
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):389-402. PubMed ID: 9044167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1990 Jun; 7(6):628-32. PubMed ID: 2367330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Feb; 93(2):364-74. PubMed ID: 14705193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.
    Cheng HY; Jusko WJ
    Pharm Res; 1988 Mar; 5(3):156-64. PubMed ID: 3244627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
    Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
    Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs.
    Watari N; Benet LZ
    J Pharmacokinet Biopharm; 1989 Oct; 17(5):593-9. PubMed ID: 2614687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
    Cheng HY; Jusko WJ
    Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion.
    Chan KK; Gibaldi M
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):551-8. PubMed ID: 7166738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple methods for estimation of mean residence time and steady-state volume of distribution from continuous-infusion data.
    Gillespie WR
    Pharm Res; 1991 Feb; 8(2):254-8. PubMed ID: 2023877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean residence time: some further considerations.
    Collier PS
    Biopharm Drug Dispos; 1989; 10(5):443-51. PubMed ID: 2804249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug redistribution and mean transit time concepts for nonlinear pharmacokinetic systems.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1991; 12(1):73-9. PubMed ID: 2039813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.